Research priorities for non-invasive therapies to improve hydrocephalus outcomes

Abstract

Abstract The Hydrocephalus Association organized two workshops with the support of the Rudi Schulte Research Institute and Cincinnati Children's Hospital Medical Center entitled “Developing Non-Invasive Hydrocephalus Therapies: Molecular and Cellular Targets”, held September 27–29, 2023, in Dallas, TX, and “Developing Non-Invasive Hydrocephalus Therapies: Advancing Towards Clinical Trials”, held April 12–13, 2024, in Cincinnati, OH. The goal of these workshops was to explore the frontiers of ongoing research for non-invasive therapies for the treatment of hydrocephalus across all etiologies and to improve patient outcomes at all stages of diagnosis and management. During the consensus-building discussions throughout the research workshops, basic, translational, and clinical scientists aimed to identify the next steps to develop novel treatments for hydrocephalus. This detailed report discusses the research priorities that emerged from these workshops to inspire researchers and guide studies towards better treatment for people living with hydrocephalus.

Keywords

• Hydrocephalus
• Pharmacotherapies
• Adjuvant therapies
• Preclinical models
• Clinical trials
• Collaboration